Metastatic Colorectal Cancers Completed Phase 1 Trials for Labetuzumab govitecan (DB12331)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01270698Study of IMMU-130 in Patients With Relapsed/Refractory Colorectal CancerTreatment